SanBio Company Limited (4592.T) JPX

Currency In JPY

AD

Valuation

Market Cap135.19B
Enterprise Value121.35B
P/E Ratio-20.16
PEG Ratio16.41
Price/Sales Ratio0
Price/Book Ratio6.4
Enterprise/Revenue0
Enterprise/EBITDA-17.51

Fiscal Year

Fiscal YearJanuary 31, 2026
Most Recent QuarterJuly 31, 2026

Profitability

Profit Margin0
Operating Margin0
AD

Management Effectiveness

Return On Assets-0.27
Return On Equity-0.38

Income Statement

Revenue0
Revenue/Share0
Gross Profit-8.05M
EBITDA-4.2B
Net Income-3.84B
Diluted EPS-52.55

Balance Sheet

Total Cash12.75B
Total Cash/Share163.32
Total Debt1.13B
Total Debt/Equity0.1
Current Ratio39.4
Book Value Per Share150.21

Price History

52-Week Change-60.43
52-Week High3,990
52-Week Low858
Moving Average 50 Days960.7
Moving Average 200 Days1,520.8

Statistics

Average Volume795,935
Shares Outstanding78.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD